erythromycin has been researched along with amoxicillin-potassium clavulanate combination in 77 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (2.60) | 18.7374 |
1990's | 29 (37.66) | 18.2507 |
2000's | 27 (35.06) | 29.6817 |
2010's | 17 (22.08) | 24.3611 |
2020's | 2 (2.60) | 2.80 |
Authors | Studies |
---|---|
Blandino, G; Caccamo, F; Di Marco, R; Nicoletti, A; Nicoletti, G; Speciale, A | 1 |
Antonova, NA; Feoktistova, GN; Petrova, MS; Shakirova, RG | 1 |
Bingen, E; Bourgeois, F; Doit, C; Lambert-Zechovsky, N; Mariani-Kurkdjian, P | 1 |
Bingen, E; Bourgeois, F; Chardon, H; Doit, C; Lambert-Zechovsky, N | 1 |
Chonmaitree, T; Hedgpeth, D; Horlick, D; Howie, VM; Owen, MJ; Patel, JA | 1 |
Balmes, P; Clerc, G; Dupont, B; Labram, C; Pariente, R; Poirier, R | 1 |
Flanagan, C; Nash, DR; Steele, LC; Wallace, RJ | 1 |
Bégué, P; Broussin, B; Garabedian, N; Quinet, B; Rivière, F; Sounthavong, JP | 1 |
Crokaert, F; Glupczynski, Y; Lismont, MJ; van der Linden, MP; Yourassowsky, E | 1 |
Flenley, DC | 1 |
Abbott, KH; Beale, AS; Smith, GM | 1 |
Bru, JP; Gaillat, J; Sedallian, A | 1 |
Nolen, T | 1 |
Overbosch, EH; Roggeveen, C; Stella, PR; van Dorp, WT; Vermeulen, EJ | 1 |
Deeble, T; Wood, GD | 1 |
Beale, AS | 1 |
Bellosta, C; Boccazzi, A; Careddu, P; Tonelli, P | 1 |
Hoepelman, AI; Neve, AJ; Rozenberg-Arska, M; Sips, AP; van Barneveld, PW; van Helmond, JL; Verhoef, J; Zwinkels, M | 1 |
Daniel, RR | 1 |
Schaad, UB | 1 |
Aubier, M; Gialdroni-Grassi, G; Hosie, J; Huchon, G; Legakis, N; Lode, H; Regamey, C; Segev, S; Tolstuchow, N; Vester, R; Wijnands, WJ | 1 |
Pillans, PI | 1 |
Huyghens, L; Lauwers, S; Meysman, M; Monsieur, I; Vincken, W | 1 |
Avdeeva, TG; Blokhin, BM; Bołko, LM; Egorova, OA; Strachynskił, LS; Stroganov, VP; Tarasova, GD | 1 |
Gizatullina, ED; Guryleva, ME; Ozol, SM; Vizel', AA | 1 |
Campbell, M; Cassell, GH; Hammerschlag, MR; Harris, JA; Kolokathis, A | 1 |
Berry, V; Knott, SJ; Thorburn, CE; Woodnutt, G | 1 |
Abramo, T; Ahmed, A; Carubelli, C; Leinonen, M; McCoig, C; McCracken, GH; Muniz, L; Trujillo, M; Wubbel, L | 1 |
Appelbaum, PC; Credito, KL; Ednie, LM; Jacobs, MR | 1 |
Charbit, Y; Fosse, TB; Hannoun, LR; Hitzig, C; Madinier, IM | 1 |
Goss, TF; Najib, MM; Stein, GE | 1 |
Hammerschlag, MR | 1 |
Mant, A | 1 |
Castaño, E; Castrejón, MM; de Atencio, I; de Morales, I; McCracken, GH; Muñiz, L; Olsen, K; Sáez-Llorens, X; Vallarino, D; Wubbel, L | 1 |
Kenyon, SL; Tarnow-Mordi, W; Taylor, DJ | 2 |
Epling, J; Grier, M; Patil, A; Weston, J; Xu, Y | 1 |
Willan, AR | 1 |
Buitendijk, SE | 1 |
Danziger, LH; Neuhauser, MM; Pendland, SL; Prause, JL | 2 |
Charbit, Y; Fosse, T; Giraud-Morin, C; Hannoun, L; Hitzig, C; Madinier, I; Ourang, S | 1 |
Neuhauser, MM; Pendland, SL; Prause, JL | 1 |
Kenyon, S; Tarnow-Mordi, WO; Taylor, DJ | 1 |
Kenyon, S; Taylor, DJ | 1 |
Aguilar, L; Cenjor, C; García-Olmos, M; Giménez, MJ; Parra, A; Ponte, C; Soriano, F | 1 |
García Vázquez, E; Marcos, MA; Martínez, JA; Mensa, J; Ortega, M; Puig, J; Torres, A | 1 |
Balatsouras, DG; Homsioglou, E; Kouskoukis, C; Rallis, E; Verros, C | 1 |
Cardinale, E; Mead, G; Perrier Gros-Claude, JD; Rivoal, K; Rose, V; Salvat, G; Tall, F | 1 |
Akçakaya, N; Alhan, E; Camcioğlu, Y; Celik, U; Diren, S; Gürler, N; Turgut, M; Yalçin, I; Yaman, A; Yildirim, B | 1 |
Benninger, MS; Brown, NP; Evangelista, AT; Sahm, DF; Thornsberry, C; Yee, YC | 1 |
Sedlacek, MJ; Walker, C | 1 |
Arguedas, A; Blumer, JL; Bradley, JS; Melkote, R; Noel, GJ; Sáez-Llorens, X | 1 |
Brocklehurst, P; Jones, D; Kenyon, S; Marlow, N; Salt, A; Taylor, D | 1 |
Brocklehurst, P; Jones, DR; Kenyon, S; Marlow, N; Pike, K; Salt, A; Taylor, DJ | 2 |
Lamont, RF | 1 |
Arija, V; Bejarano-Romero, F; Cliville-Guasch, X; de Diego, C; Gomez-Bertomeu, F; Ochoa-Gondar, O; Raga-Luria, X; Salsench, E; Vila-Corcoles, A | 1 |
Bucki, R; Janmey, PA; Leszczyńska, K; Namiot, A | 1 |
Dixon-Woods, M; Jackson, CJ; Jones, DR; Kenyon, S; Tarrant, C | 1 |
Bower, E; Brocklehurst, P; Jones, D; Kenyon, S; Kurinczuk, JJ; Marlow, N; Pike, K; Salt, A; Taylor, D | 1 |
Chang, AB; Gavranich, JB; Gillies, MB; Mulholland, S | 1 |
Degener, JE; Feik, D; Mortensen, JE; Rams, TE; van Winkelhoff, AJ | 1 |
Achiraman, S; Anandhakumar, S; Antony, JJ; Raichur, AM; Siva, D; Sripriya, J | 1 |
Lanier, J; Qui, MK; Shim, J | 1 |
Chang, AB; Gardiner, SJ; Gavranich, JB | 1 |
Gao, W; He, M; Shi, W; Yang, Y; Yao, K; Yu, S; Yuan, L | 1 |
Bower, H; Brocklehurst, P; Jones, D; Kenyon, S; Marlow, N; Pike, K; Salt, A; Taylor, D | 1 |
Bannister, CA; Berni, E; Butler, CC; Currie, CJ; de Voogd, H; Halcox, JP; Jenkins-Jones, S; Jones, B; Ouwens, M | 1 |
Bottieau, E; Hallin, M; Jacobs, J; Maniewski, U; Martiny, D; Ombelet, S; Post, A; Van Esbroeck, M; van Waterschoot, N; Vandenberg, O; Vlieghe, E | 1 |
Bahaduri, MA; Naimi, HM; Noori, AZ; Rasekh, H | 1 |
Oka, S; Otani, I; Tanaka, S | 1 |
Abou-Khadra, SH; Aggour, MG; El-Azzouny, MM; El-Demerdash, AS | 1 |
Chang, AB; Marchant, JM; Morris, PS; Petsky, HL | 1 |
Celi, F; Esposito, S; Marchese, L; Miconi, F; Miconi, G; Molinari, D; Principi, N; Savarese, E; Valloscuro, S | 1 |
Djilas, M; Marković, M; Milosavljević, B; Petrović, V; Ristić, M | 1 |
Chen, WC; Hung, JN; Lin, LL; Shiu, SI; Su, YH; Tseng, JJ | 1 |
8 review(s) available for erythromycin and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
New drugs in respiratory disorders: II.
Topics: Adult; Aged; Amantadine; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Cyclophosphamide; Drug Combinations; Erythromycin; Ethambutol; Humans; Metronidazole; Pyrazinamide; Respiratory Tract Diseases; Respiratory Tract Infections; Rifampin; Trimethoprim; Tuberculosis, Pulmonary | 1983 |
Comparative studies of cefprozil in the management of skin and soft-tissue infections.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Skin Diseases, Bacterial; Soft Tissue Infections | 1994 |
[Erythromycin for premature rupture of membranes is beneficial for infant].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Drug Therapy, Combination; Enterocolitis, Necrotizing; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Randomized Controlled Trials as Topic | 2001 |
Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bronchitis; Child; Community-Acquired Infections; Erythromycin; Humans; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Randomized Controlled Trials as Topic | 2012 |
Clinical inquiry: what is the best treatment for impetigo ?
Topics: Administration, Topical; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacitracin; Bridged Bicyclo Compounds, Heterocyclic; Cephalexin; Clindamycin; Cloxacillin; Dicloxacillin; Diterpenes; Erythromycin; Fusidic Acid; Gentamicins; Humans; Impetigo; Meta-Analysis as Topic; Mupirocin; Randomized Controlled Trials as Topic | 2014 |
Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bronchitis; Child; Community-Acquired Infections; Erythromycin; Humans; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Randomized Controlled Trials as Topic | 2015 |
Antibiotics for prolonged wet cough in children.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Child; Child, Preschool; Chronic Disease; Cough; Disease Progression; Erythromycin; Humans; Infant; Intention to Treat Analysis; Randomized Controlled Trials as Topic; Sputum | 2018 |
Efficacy of prophylactic antibiotics for preterm premature rupture of membranes: a systematic review and network meta-analysis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Chorioamnionitis; Clindamycin; Erythromycin; Female; Gentamicins; Humans; Infant, Newborn; Macrolides; Network Meta-Analysis; Pregnancy; Premature Birth | 2023 |
17 trial(s) available for erythromycin and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
Effect of viral respiratory tract infection on outcome of acute otitis media.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cefpodoxime; Ceftizoxime; Clarithromycin; Clavulanic Acids; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Male; Otitis Media; Respiratory Tract Infections; Treatment Outcome; Virus Diseases | 1992 |
Comparative study of azithromycin and amoxicillin/clavulanic acid in the treatment of lower respiratory tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Azithromycin; Bronchitis; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Streptococcus pneumoniae | 1991 |
[Acute otitis media in children: a randomized and open clinical trial of the efficacy of 2 major antibiotics (erythromycin ethylsuccinate/acetyl sulfafurazole vs amoxicillin/clavulanic acid)].
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Child, Preschool; Clavulanic Acids; Drug Combinations; Drug Therapy, Combination; Drug Tolerance; Erythromycin; Female; Humans; Infant; Male; Otitis Media; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Sulfisoxazole | 1990 |
Penicillin G/ofloxacin versus erythromycin/amoxicillin-clavulanate in the treatment of severe community-acquired pneumonia.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acids; Community-Acquired Infections; Drug Therapy, Combination; Drug Tolerance; Erythromycin; Female; Humans; Male; Middle Aged; Ofloxacin; Penicillin G; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Streptococcus pneumoniae; Treatment Outcome | 1994 |
Efficacy and tolerability of brodimoprim in pediatric infections.
Topics: Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Erythromycin; Humans; Otitis Media; Pharyngitis; Respiratory Tract Infections; Sinusitis; Tonsillitis; Trimethoprim | 1993 |
A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Azithromycin; Bronchitis; Clavulanic Acids; Drug Administration Schedule; Drug Combinations; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Moraxella catarrhalis; Neisseriaceae Infections; Pneumococcal Infections; Respiratory Tract Infections; Single-Blind Method; Streptococcus pneumoniae | 1993 |
Comparison of azithromycin and co-amoxiclav in the treatment of otitis media in children.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Azithromycin; Child; Child, Preschool; Clavulanic Acids; Drug Combinations; Erythromycin; Female; Humans; Infant; Male; Otitis Media | 1993 |
Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Azithromycin; Child; Child, Preschool; Clavulanic Acids; Drug Administration Schedule; Drug Combinations; Erythromycin; Female; Humans; Infant; Male; Otitis Media | 1993 |
Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Penicillins; Pneumonia, Bacterial; Quinolones; Streptococcus pneumoniae | 1996 |
Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Chlamydia Infections; Chlamydophila pneumoniae; Communicable Diseases; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Male; Mycoplasma pneumoniae; Pneumonia, Bacterial; Pneumonia, Mycoplasma | 1998 |
Etiology and treatment of community-acquired pneumonia in ambulatory children.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Viral; Azithromycin; Child; Child, Preschool; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Humans; Infant; Nasopharynx; Outpatient Clinics, Hospital; Pneumonia, Bacterial; Pneumonia, Viral; Prospective Studies | 1999 |
[Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia].
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Chlamydophila pneumoniae; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Male; Mycoplasma pneumoniae; Pneumonia, Bacterial; Pneumonia, Mycoplasma | 1998 |
Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Drug Therapy, Combination; Enterocolitis, Necrotizing; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Treatment Outcome | 2001 |
Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE Collaborative Group.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Drug Therapy, Combination; Drug Utilization; Enterocolitis, Necrotizing; Erythromycin; Female; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Treatment Outcome | 2001 |
ORACLE--antibiotics for preterm prelabour rupture of the membranes: short-term and long-term outcomes.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Follow-Up Studies; Humans; Infant, Newborn; Pregnancy; Pregnancy Outcome; Reference Values; Risk Assessment; Treatment Outcome | 2002 |
Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Ofloxacin; Pneumonia; Treatment Outcome | 2007 |
MRC ORACLE Children Study. Long term outcomes following prescription of antibiotics to pregnant women with either spontaneous preterm labour or preterm rupture of the membranes.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Child; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Follow-Up Studies; Humans; Obstetric Labor, Premature; Outcome Assessment, Health Care; Pregnancy; Research Design; Surveys and Questionnaires; Treatment Outcome | 2008 |
52 other study(ies) available for erythromycin and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
Bactericidal activity and postantibiotic effect of cefdinir (Cl 983, FK 482) against selected pathogens.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefdinir; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Erythromycin; Kinetics; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
[Antibiotic therapy in children with pertussis].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Clavulanic Acids; Cross Infection; Erythromycin; Humans; Infant; Infant, Newborn; Whooping Cough | 1992 |
In-vitro bactericidal activity of four oral antibiotics against pathogens responsible for acute otitis media in children.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefaclor; Child, Preschool; Clavulanic Acids; Colony Count, Microbial; Drug Therapy, Combination; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Haemophilus influenzae; Humans; Infant; Microbial Sensitivity Tests; Moraxella catarrhalis; Otitis Media; Staphylococcus aureus; Streptococcus pneumoniae; Sulfisoxazole | 1992 |
Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Child; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis | 1992 |
Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae.
Topics: Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythromycin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Tetracycline | 1991 |
Rate of bactericidal activity for Branhamella catarrhalis of a new macrolide, CP-62,993, compared with that of amoxicillin-clavulanic acid.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Azithromycin; Clavulanic Acids; Drug Combinations; Erythromycin; Humans; Moraxella catarrhalis; Time Factors | 1988 |
Combined therapy with co-amoxiclav and erythromycin against intracellular Legionella pneumophila in cell culture and in an experimental respiratory infection in neutropenic rats.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Cells, Cultured; Clavulanic Acids; Cyclophosphamide; Drug Therapy, Combination; Erythromycin; Fibroblasts; Humans; Legionella pneumophila; Legionnaires' Disease; Lung; Male; Microbial Sensitivity Tests; Neutropenia; Rats | 1995 |
Systemic infection with Nocardia asteroides cured with amoxicillin/clavulanic acid, erythromycin and ultrasound-guided transcutaneous aspiration.
Topics: Abscess; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acids; Drug Therapy, Combination; Erythromycin; Female; Humans; Nocardia asteroides; Nocardia Infections; Suction; Ultrasonography, Interventional | 1994 |
Warfarin: dangers with antibiotics.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clavulanic Acids; Dental Care for Chronically Ill; Drug Interactions; Erythromycin; Female; Humans; Male; Middle Aged; Warfarin | 1993 |
Efficacy of co-amoxiclav compared with other beta-lactams, quinolones, tetracyclines and erythromycin against an experimental Chlamydia trachomatis respiratory infection.
Topics: 4-Quinolones; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Clavulanic Acids; Drug Therapy, Combination; Erythromycin; Female; Mice; Respiratory Tract Infections; Tetracyclines | 1993 |
Drug associated hepatic reactions in New Zealand: 21 years experience.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anesthetics, Inhalation; Anti-Bacterial Agents; Anti-Inflammatory Agents; Calcium Channel Blockers; Cardiovascular Agents; Cause of Death; Clavulanic Acids; Diclofenac; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Floxacillin; Halothane; Humans; Liver; Male; Middle Aged; New Zealand; Penicillins; Perhexiline; Steroids | 1996 |
Severe community-acquired pneumonia caused by atypical organisms.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Clavulanic Acids; Community-Acquired Infections; Critical Care; Diagnosis, Differential; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Psittacosis; Radiography; Treatment Failure | 1997 |
[Pharmacoepidemiology of antibiotics in the treatment of respiratory tract infections in pediatric outpatients].
Topics: Adolescent; Ambulatory Care; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Analgesics, Non-Narcotic; Bronchodilator Agents; Child; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Erythromycin; Gentamicins; Histamine Antagonists; Humans; Infant; Injections, Intramuscular; Penicillin G; Penicillins; Respiratory Tract Infections; Retrospective Studies; Russia; Treatment Outcome | 1997 |
[Antibiotic sensitivity of pathogenic microflora: data of the bacteriological laboratory at the antituberculosis clinic].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Carbenicillin; Cefuroxime; Cephalexin; Cephalosporins; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Inpatients; Lincomycin; Male; Microbial Sensitivity Tests; Neomycin; Outpatients; Oxacillin; Penicillins; Rifampin; Spiramycin; Streptomycin; Tetracycline | 1998 |
Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Clarithromycin; Drug Therapy, Combination; Erythromycin; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 1998 |
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; beta-Lactamases; Clarithromycin; Clindamycin; Drug Therapy, Combination; Erythromycin; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Ketolides; Macrolides; Metronidazole; Microbial Sensitivity Tests; Roxithromycin; Virginiamycin | 1999 |
Resistance profile survey of 50 periodontal strains of Actinobacillus actinomyectomcomitans.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Microbial; Erythromycin; Humans; Metronidazole; Microbial Sensitivity Tests; Ornidazole; Periodontal Pocket; Periodontitis; Species Specificity; Spiramycin; Tetracycline; Virginiamycin | 1999 |
Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Azithromycin; Cefaclor; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Erythromycin; Fluoroquinolones; Humans; Models, Economic; Outpatients; Pneumonia; Treatment Outcome | 2000 |
Treatment of Chlamydia pneumoniae.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antibodies, Bacterial; Azithromycin; Child; Child, Preschool; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Erythromycin; Humans; Pneumonia, Bacterial | 2000 |
Choosing the most appropriate antibiotic for respiratory infections.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Australia; Cephalexin; Child, Preschool; Clinical Competence; Drug Utilization; Erythromycin; Family Practice; Female; Guidelines as Topic; Humans; Male; Practice Patterns, Physicians'; Respiratory Tract Infections | 2000 |
Do antibiotics improve neonatal outcomes in preterm premature rupture of membranes (PPROM)?
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Infant, Premature, Diseases; Multicenter Studies as Topic; Obstetric Labor, Premature; Pregnancy; Randomized Controlled Trials as Topic | 2001 |
Broad-spectrum antibiotics in ORACLE.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Pregnancy | 2001 |
Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Ketolides; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae | 2001 |
High prevalence of cfxA beta-lactamase in aminopenicillin-resistant Prevotella strains isolated from periodontal pockets.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Drug Therapy, Combination; Erythromycin; Fimbriae Proteins; Genes, Bacterial; Humans; Membrane Proteins; Penicillin Resistance; Penicillins; Periodontal Pocket; Periodontitis; Phenotype; Polymerase Chain Reaction; Prevotella; Prospective Studies; Tetracycline; Tetracycline Resistance | 2002 |
In vitro bactericidal activity and post-antibiotic effect of ABT-773 versus co-amoxiclav against anaerobes.
Topics: Amoxicillin-Potassium Clavulanate Combination; Bacteria, Anaerobic; Bacteroides fragilis; Drug Therapy, Combination; Erythromycin; Ketolides; Kinetics; Microbial Sensitivity Tests; Peptostreptococcus | 2002 |
The effect of the publication of a major clinical trial in a high impact journal on clinical practise: the ORACLE Trial experience.
Topics: Amoxicillin-Potassium Clavulanate Combination; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Hospitals, Maternity; Humans; Maternal Health Services; Obstetric Labor, Premature; Practice Patterns, Physicians'; Pregnancy; Prenatal Care; Publishing; Randomized Controlled Trials as Topic; Surveys and Questionnaires; United Kingdom | 2002 |
In vitro bactericidal activities of ABT-773 against ermB strains of Streptococcus pneumoniae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalosporins; Culture Media; Drug Therapy, Combination; Erythromycin; Humans; Ketolides; Kinetics; Methyltransferases; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae | 2003 |
In vivo activity of amoxicillin/clavulanic acid and erythromycin in experimental otitis media caused by Streptococcus pneumoniae plus Haemophilus influenzae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Disease Models, Animal; Drug Therapy, Combination; Erythromycin; Gerbillinae; Haemophilus Infections; Haemophilus influenzae; Microbial Sensitivity Tests; Otitis Media; Pneumococcal Infections; Streptococcus pneumoniae | 2004 |
Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefotaxime; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Humans; Pneumonia, Bacterial | 2005 |
Drug eruptions in children with ENT infections.
Topics: Acetaminophen; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Child; Child, Preschool; Clarithromycin; Clindamycin; Diagnosis, Differential; Drug Eruptions; Erythromycin; Female; Humans; Infant; Infections; Male; Otitis; Otorhinolaryngologic Diseases; Pharyngitis; Prospective Studies; Rhinitis; Risk Factors; Sinusitis; Stomatognathic Diseases; Tonsillitis | 2006 |
Genetic characterization and antibiotic resistance of Campylobacter spp. isolated from poultry and humans in Senegal.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter coli; Campylobacter jejuni; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Food Microbiology; Genes, Bacterial; Genetic Variation; Genotype; Humans; Nalidixic Acid; Poultry; Quinolones | 2006 |
Serotype distribution and antibiotic susceptibility of invasive Streptococcus pneumoniae disease isolates from children in Turkey, 2001-2004.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Drug Resistance, Bacterial; Erythromycin; Humans; Infant; Microbial Sensitivity Tests; Penicillin G; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey | 2006 |
Antimicrobial resistance trends among sinus isolates of Streptococcus pneumoniae in the United States (2001-2005).
Topics: Acetamides; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; Cefuroxime; Cephalosporin Resistance; Clindamycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Levofloxacin; Linezolid; Ofloxacin; Oxazolidinones; Paranasal Sinuses; Penicillin Resistance; Population Surveillance; Streptococcus pneumoniae; Trimethoprim Resistance; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2007 |
Antibiotic resistance in an in vitro subgingival biofilm model.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Clindamycin; Dental Pellicle; Dental Plaque; Dose-Response Relationship, Drug; Doxycycline; Drug Resistance, Bacterial; Durapatite; Erythromycin; Gingiva; Gram-Negative Bacteria; Humans; Metronidazole; Middle Aged; Minocycline; Periodontitis; Tetracycline; Time Factors | 2007 |
Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Child; Child Mortality; Child Welfare; Educational Status; England; Erythromycin; Female; Fetal Membranes, Premature Rupture; Follow-Up Studies; Health Status; Humans; Logistic Models; Male; Pelvic Infection; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome | 2008 |
Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial.
Topics: Activities of Daily Living; Adult; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Cerebral Palsy; Child; Child Mortality; Educational Status; England; Erythromycin; Female; Follow-Up Studies; Health Status; Humans; Logistic Models; Male; Obstetric Labor, Premature; Pelvic Infection; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Treatment Outcome | 2008 |
Association between cerebral palsy and erythromycin.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cerebral Palsy; Erythromycin; Female; Genital Diseases, Female; Humans; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious | 2009 |
Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Blood; Cefotaxime; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Oxacillin; Pneumococcal Infections; Serotyping; Spain; Sputum; Streptococcus pneumoniae | 2009 |
Modulation of exogenous antibiotic activity by host cathelicidin LL-37.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cathelicidins; Drug Synergism; Erythromycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 2010 |
Providing the results of research to participants: a mixed-method study of the benefits and challenges of a consultative approach.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Disclosure; Erythromycin; Feedback; Female; Fetal Membranes, Premature Rupture; Focus Groups; Humans; Pregnancy; Pregnancy Complications; Referral and Consultation; Research Subjects; Surveys and Questionnaires; Treatment Outcome | 2011 |
Characteristics of children with cerebral palsy in the ORACLE children study.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Birth Weight; Cerebral Palsy; Child; Educational Status; Erythromycin; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Male; Morbidity; Mothers; Movement Disorders; Multiple Birth Offspring; Obstetric Labor, Premature; Poverty; Pregnancy; Premature Birth; Severity of Illness Index | 2012 |
Antibiotic susceptibility of periodontal Enterococcus faecalis.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Chronic Periodontitis; Ciprofloxacin; Clindamycin; Dental Plaque; Drug Resistance, Bacterial; Enterococcus faecalis; Erythromycin; Female; Gingiva; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Periodontal Pocket; Periodontitis; Teicoplanin; Tetracycline Resistance; Vancomycin | 2013 |
Laser receptive polyelectrolyte thin films doped with biosynthesized silver nanoparticles for antibacterial coatings and drug delivery applications.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bacteria; Dextran Sulfate; Drug Delivery Systems; Erythromycin; Fluoroquinolones; Lasers; Metal Nanoparticles; Moxifloxacin; Plant Extracts; Plant Leaves; Polyamines; Quinolines; Silver; Violaceae | 2013 |
Dynamics of serotype 14 Streptococcus pneumoniae population causing acute respiratory infections among children in China (1997-2012).
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Child, Preschool; China; Drug Resistance, Bacterial; Erythromycin; Humans; Infant; Infant, Newborn; Multilocus Sequence Typing; Pneumococcal Infections; Polymerase Chain Reaction; Respiratory Tract Infections; Serogroup; Streptococcus pneumoniae | 2015 |
The ORACLE Children Study: educational outcomes at 11 years of age following antenatal prescription of erythromycin or co-amoxiclav.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Child; Child Development; Databases, Factual; Educational Measurement; England; Erythromycin; Female; Humans; Male; Outcome Assessment, Health Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects | 2017 |
Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Cause of Death; Clarithromycin; Doxycycline; Erythromycin; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Risk Factors; United Kingdom | 2017 |
Antibiotic susceptibility profiles among Campylobacter isolates obtained from international travelers between 2007 and 2014.
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Child; Child, Preschool; Ciprofloxacin; Communicable Diseases, Imported; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Thienamycins; Young Adult | 2017 |
Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Topics: Adolescent; Adult; Afghanistan; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Child; Child, Preschool; Clindamycin; Erythromycin; Female; Health Facilities; Humans; Infant; Longitudinal Studies; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2017 |
Case of small intestinal bacterial overgrowth carried out by capsule and double-balloon endoscopy.
Topics: Abdominal Pain; Aged; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Capsule Endoscopy; Double-Balloon Enteroscopy; Enterococcus faecalis; Erythromycin; Escherichia coli; Female; History, 18th Century; Humans; Intestinal Diseases; Severity of Illness Index; Treatment Outcome | 2018 |
Molecular analysis of integron gene cassette arrays associated multi-drug resistant Enterobacteriaceae isolates from poultry.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Chickens; Drug Resistance, Bacterial; Egypt; Enterobacteriaceae; Enterobacteriaceae Infections; Erythromycin; Farms; Gene Expression Regulation, Bacterial; Genes, Bacterial; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Poultry; Poultry Diseases; Rifamycins | 2018 |
What is the role of Ewingella americana in humans? A case report in a healthy 4-year-old girl.
Topics: Administration, Oral; Aminoglycosides; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxime; Child, Preschool; Enterobacteriaceae; Erythromycin; Female; Fluoroquinolones; Humans; Italy; Pneumonia; Thorax | 2019 |
Pneumococcal carriage in adults aged 50 years and older in outpatient health care facility during pandemic COVID-19 in Novi Sad, Serbia.
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Carrier State; Ceftriaxone; Child; COVID-19; Delivery of Health Care; Erythromycin; Female; Humans; Infant; Levofloxacin; Middle Aged; Nasopharynx; Outpatients; Pandemics; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; Serbia; Serogroup; Streptococcus pneumoniae; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |